Panos Konstantinopoulos, MD, PhD shares results of a phase 2 endometrial cancer study at 2022 SGO.
2 Mga view
administrator
07/17/23
Panos Konstantinopoulos, MD, PhD shares results of a phase 2, two-stage study of letrozole and abemaciclib in estrogen receptor (ER) positive recurrent or persistent endometrial cancer at the 2022 Society for Gynecologic Oncology Annual Meeting.
Magpakita ng higit pa
Mga Komento sa Facebook
Walang nakitang komento